Delivery Order SPE2DB20D7066-SPE2DB26FC1MD
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Procainamide 1 gram/10 mL vials. This competitive, non-set-aside award carries a ceiling value of $3,145.00 and is scheduled for completion by August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,505.03. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $3,164.53. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $7,809.52 on September 16, 2025, for the supply of Procainamide 1 gram/10 mL vials (10 mL quantity). This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on September 17, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract does not utilize a set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,137.63. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a contract ceiling value of $4,296.26. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award represents...
- The Defense Logistics Agency awarded a delivery order valued at $4,352.76 to AmerisourceBergen Drug Corp for the supply of Procainamide 1,000 mg/2 mL vials. This contract, which was competitively awarded without set-aside provisions, carries a firm fixed price and an ultimate completion date of August 4, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 vehicle...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.11 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on August 27, 2025. This firm fixed price delivery order, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Procainamide 1 gram/10 mL vials totaling $1,539.32 on September 4, 2025, with completion due by September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...